- Home
- ALTO vs ONCY Comparison
ALTO vs ONCY Comparison
Compare ALTO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTO
- ONCY
- Stock Information
- Founded
- ALTO 2003
- ONCY 1998
- Country
- ALTO United States
- ONCY Canada
- Employees
- ALTO N/A
- ONCY N/A
- Industry
- ALTO Major Chemicals
- ONCY Pharmaceuticals and Biotechnology
- Sector
- ALTO Industrials
- ONCY Health Care
- Exchange
- ALTO Nasdaq
- ONCY Nasdaq
- Market Cap
- ALTO 95.7M
- ONCY 89.7M
- IPO Year
- ALTO N/A
- ONCY 1999
- Fundamental
- Price
- ALTO $1.05
- ONCY $0.99
- Analyst Decision
- ALTO Strong Buy
- ONCY Strong Buy
- Analyst Count
- ALTO 1
- ONCY 4
- Target Price
- ALTO $5.50
- ONCY $4.33
- AVG Volume (30 Days)
- ALTO 192.4K
- ONCY 1.3M
- Earning Date
- ALTO 08-06-2025
- ONCY 08-12-2025
- Dividend Yield
- ALTO N/A
- ONCY N/A
- EPS Growth
- ALTO N/A
- ONCY N/A
- EPS
- ALTO N/A
- ONCY N/A
- Revenue
- ALTO $951,169,000.00
- ONCY N/A
- Revenue This Year
- ALTO N/A
- ONCY N/A
- Revenue Next Year
- ALTO $7.68
- ONCY N/A
- P/E Ratio
- ALTO N/A
- ONCY N/A
- Revenue Growth
- ALTO N/A
- ONCY N/A
- 52 Week Low
- ALTO $0.76
- ONCY $0.33
- 52 Week High
- ALTO $2.05
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- ALTO 38.42
- ONCY 48.40
- Support Level
- ALTO $1.13
- ONCY $1.00
- Resistance Level
- ALTO $1.28
- ONCY $1.11
- Average True Range (ATR)
- ALTO 0.07
- ONCY 0.09
- MACD
- ALTO -0.03
- ONCY -0.05
- Stochastic Oscillator
- ALTO 25.81
- ONCY 9.95
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.